Cargando…
Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidinone antibiotic with in vitro activity against some NTM, but...
Autores principales: | Shaw, Timothy David, Smyth, Mark, Turner, Graham, Hunter, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322297/ https://www.ncbi.nlm.nih.gov/pubmed/34355067 http://dx.doi.org/10.1016/j.jctube.2021.100261 |
Ejemplares similares
-
Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
por: Ruth, Mike Marvin, et al.
Publicado: (2020) -
Two Episodes of Cutaneous Non-Tuberculous Mycobacterial Infection in a Patient with Psoriasis
por: Chan, Wai Sze Agnes, et al.
Publicado: (2015) -
Non-Tuberculous Mycobacterial Diseases in Children
por: Meoli, Aniello, et al.
Publicado: (2020) -
1289. Assessing the Safety and Efficacy with Prolonged Use of Tedizolid in Orthopedic Patients
por: Garza, Daniel E, et al.
Publicado: (2023) -
Whole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections
por: Dohál, Matúš, et al.
Publicado: (2021)